Empagliflozin Use in Cardiac Transplant Patients: <i>Real-world experience from Saudi Arabia</i>

Although larger studies are needed to examine the use of empagliflozin in cardiac transplant patients, this small study provides assurance that empagliflozin is safe for use in cardiac transplant recipients.

Authors

Institutions

Publication Details

Journal
Sultan Qaboos University medical journal
Published
2024-10-31
DOI
https://doi.org/10.18295/squmj.10.2024.057
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Empagliflozin Use in Cardiac Transplant Patients: Real-world experience from Saudi Arabia

Roaa MH Albalwi, Muhammad Imran Butt, Norah Alnassar, Reem Alghambi
Sultan Qaboos University medical journal
Transplantation: Methods and Outcomes
article

Empagliflozin Use in Cardiac Transplant Patients: Real-world experience from Saudi Arabia

Roaa MH Albalwi, Muhammad Imran Butt, Norah Alnassar, Reem Alghambi
article en

Abstract

Although larger studies are needed to examine the use of empagliflozin in cardiac transplant patients, this small study provides assurance that empagliflozin is safe for use in cardiac transplant recipients.

Sultan Qaboos University medical journalVol. 25(1)
Alfaisal University (SA), King Faisal Specialist Hospital & Research Centre (SA)
Good health and well-being
Openalex Percentile: Top 63%
Transplantation: Methods and Outcomes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.